Skinbooster for the cheekbones and cheeks: what to expect

Skinbooster is the injection of low cross-linked hyaluronic acid, or of formulations designed to hydrate, into the superficial layer of the skin. In the cheekbone area and cheeks it fits the plan of someone who complains of dull, thin or unevenly textured skin, not of someone who has lost projection. This difference seems obvious among colleagues, but it is the source of most frustrations in the office.

This text organizes what to expect from skinbooster in this area, where it ends and where cheekbone filler begins, what the risks are and how to align expectations before injecting. Product, dilution, technique and intervals are decisions for the licensed professional, following the package insert and the rules of their professional council. Nothing here is an injection protocol.

What does skinbooster do in the cheeks?

Hyaluronic acid attracts water. In low-viscosity formulations placed in the superficial dermis, the idea is to increase tissue hydration and improve the skin's radiance and softness. The mechanism is tied to the hydrophilicity of hyaluronic acid and to the rheological properties of the gel: the more fluid and less cohesive it is, the less capacity it has to hold volume and the more easily it spreads evenly.

In practice, the patient describes the result as "plumper-looking skin" or "less tired skin", and rarely as "a higher cheek". Someone who expects the second and gets the first feels there was no effect, even if the skin improved. Recording the complaint beforehand, in the patient's own words, prevents that reading.

What it does not do

• It does not replace the malar fat pad or the bone loss of the midface.
• It does not substitute for the cheekbone projection that cheekbone filler aims for.
• It does not treat ligament laxity or midface ptosis.
• It does not correct deep folds such as the nasolabial fold at rest.

Who is usually a candidate?

The profile that benefits most is the patient with dry cheek skin, visible pores and a matte look, without major volume loss. It also appears in those with mild signs of photoaging who want to improve skin quality before an event or as a preparatory step for another procedure.

The indication calls for an assessment of context. Skin with active inflammatory acne, local infection, dermatitis or a tendency to abnormal healing calls for caution and often postponement. A known allergy to product components, pregnancy and breastfeeding are part of the medical history and of the professional's decision.

Questions that help separate hydration from volume

1. What bothers you: the skin or the shape of the cheek?
2. In photos from a few years ago, was the contour of the cheek different?
3. Does the concern get worse under overhead light, which suggests volume loss and shadow?
4. Is there a feeling of "tight" or dry skin, even with moisturizer?

If the answers point to shape, skinbooster may be a complement, not the main plan. Assessing the midface as a whole, including the facial assessment by thirds, organizes this conversation.

Skinbooster, cheekbone filler and biostimulator: how to tell them apart

The table is a conversation guide, not a rule. The biostimulator for the cheeks has its own page, and the relationship with polynucleotides is in skinbooster vs. polynucleotides.

Possible risks and complications

Because it is superficial and uses small volumes per area, skinbooster tends to have a milder risk profile than deep fillers, but that does not mean no events occur. The most discussed:

• Ecchymosis and swelling: common and self-limiting in most cases. They usually resolve within days.
• Papules and irregularities: product placed in the dermis can form bumps that settle over time. Persistence calls for reassessment.
• Tyndall effect: gel that is too superficial can give the skin a bluish tint. It is discussed more in thin skin, and hyaluronidase is a correction option when the professional indicates it.
• Infection and viral reactivation: asepsis and a history of herpes are part of the assessment.
• Vascular occlusion: rare with a superficial technique and small volumes, but the possibility exists with every hyaluronic acid injection. Knowing the vascular danger zones of the face and having hyaluronidase available is part of the preparation.
• Hypersensitivity reactions and late nodules: require clinical follow-up.

How to combine skinbooster with other approaches

In many plans, skinbooster is a layer: first you decide what needs structure, then what needs skin quality. This logic avoids applying hydration to a concern that is actually about volume.

Common combinations in office literature, always subject to the professional's decision:

• Skinbooster with microneedling, in texture protocols.
• Skinbooster followed by biostimulation, when the goal includes firmness.
• Cheekbone filler in one session and skinbooster in another, so that swelling does not add up.

The interval between sessions and the order depend on the product, the expected swelling and the patient. Recording what was done and when, with standardized clinical photography, is what allows you to evaluate the real contribution of each step.

How to explain it to the patient in one sentence

Patients understand better when the explanation is concrete and short. Some useful phrasings:

Where Harmy fits into this planning

Harmy does not simulate skinbooster, because the app works with volume by area and hydration does not change the contour that the projection shows. What the app does help with is separating concerns: when the patient wants more projection, marking the Cheekbone point with the chosen ml shows the effect of volume, and it becomes clear what a skinbooster alone would not deliver.

Showing the cheekbone volume projection alongside the conversation about hydration helps the patient understand that these are two answers to two different questions. That clarity tends to reduce the insistence on "I only want what gives more glow" when the concern is projection, and the other way around.

Consultation checklist for cheekbone skinbooster

Myth or fact?

Points of attention when advertising

When communicating the procedure, avoid promising a lift, filler "without swelling" or the same result for everyone. Follow what the page on what you can advertise advises (under Brazil's CFO and CONAR rules) and never present a simulation as if it were an actual result. Recording consent and using the patient's image have their own rules, described in consent and LGPD for photos (Brazil's data protection law).

In short: skinbooster for the cheekbones and cheeks is a skin quality tool, useful when the concern is hydration and texture. When the concern is shape, it does not replace volume or support, and saying so in the consultation is the best way to protect the perceived result and the relationship with the patient.